TSPAN1 inhibition with these new siRNAs (siRNA#2 and siPool) decreased cell proliferation and sensitized HNSCC cells to the effects of CDDP, corroborating our previous results (Figure S2) [28]. Here, TSPAN1 is linked to head and neck squamous cell carcinoma.